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Abstract
Background: A maternal line of inheritance regarding eczema has been described in several studies, whereas
others find associations to both a maternal as well as a paternal line of inheritance. When studying family history
of eczema symptoms, cohort studies including siblings are rare. Time point for assessing family eczema-history
could be of importance when studying the associations between family eczema-history and children with eczema,
as parents with unaffected children may not recall mild symptoms in other siblings or their own disease history.
We therefore aimed to study the associations between reported eczema in mother, father and siblings and
reported eczema in index child where information on family history was collected at two different ages of index
child.
Methods: Parents/children participating in The Prevention of Allergy among Children in Trondheim (PACT) study
were given questionnaires on reported eczema symptoms in mother, father and siblings at 6 weeks and 1 year.
When index child was 2 years of age, a detailed questionnaire on different health issues with emphasize on
different allergy related disorders were filled in.
Results: Both maternal and paternal reports on eczema were significantly associated with eczema in index child.
Reporting family eczema-history at 1 year (N = 3087), “eczema sibling only” [adjusted odds ratio (aOR) = 3.13 (2.27-
4.33)] as well as all other family-groups containing siblings with eczema were strongly associated with eczema 2
years. When family eczema-history was reported at 6 weeks (N = 2657), reporting of “eczema sibling only” was not
associated to reported eczema at 2 years in index child [aOR = 1.31 (0.77-2.23)].
Conclusions: Having sibling(s) with eczema strengthened the associations between maternal and paternal reports
on eczema with eczema in index child only when exposure was reported at 1 year. These findings indicate that
results from questionnaires-based studies of family eczema-history depend on whether or not index child has yet
developed eczema.
Trial registration: ISRCTN: ISRCTN28090297
Background
Atopic eczema is a complex disease caused by a mainly
unknown interaction between genetic and environmen-
tal factors [1]. The genetic component of the disease has
been demonstrated in twin studies [2], and several stu-
dies have emphasized the association of atopy in the
mother with the development of atopic eczema in the
child whereas the evidence for association to an atopic
father has been somewhat weaker [3-6]. In the last
years, however, other studies have concluded that the
association with both paternal as well as maternal atopy
is important in the development of allergic disease in
the offspring [7-10] Several candidate genes linked to
the development of eczema have been identified [11],
but so far only mutations in the gene encoding filaggrin
(FLG) have been widely replicated [12].
When family eczema-history is studied, several investi-
gators have studied the protective effect of having a high
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eases [13,14]. However, few prospective studies from the
general population have addressed the association
between allergy related disorders in older siblings and
the child under study [4,15].
When studying diseases in the general population,
self-reported questionnaires are often used. One of the
flaws with such information could be recall bias con-
cerning how well adults remember both their own child-
hood diseases as well as diseases in children with mild
symptoms [16-18].
The aim of this prospective study was therefore to
investigate the associations between reported eczema in
mother, father and siblings and reported eczema in
index child at 2 years of age where family eczema-his-
tory as well as exposure was collected at two different
ages of the index child.
Methods
The Prevention of Allergy among Children in Trond-
heim (PACT) study is a large population- based pro-
spective study on allergy related disorders conducted in
Trondheim, central Norway. Trondheim has approxi-
mately 165 000 inhabitants and 2100 deliveries pr year.
From September 2000 all pregnant women as well as
children 6 weeks, 1 year, and 2 years of age visiting
their general practitioner or community based midwife
were consecutively invited to attend the study. Women/
parents were eligible to participate if they were able to
complete a questionnaire in Norwegian. Recruitment of
6 weeks old, 1 year and 2 years old children closed June
30
th 2006. The PACT-study is described in further detail
elsewhere [19].
-Study design
Family eczema-history and exposure variables was
assessed from questionnaires when the child was 6
weeks old (Q2) and 1 year old (Q3) [19]. When the
child was approximately 2 years of age, the parents
answered a questionnaire on the child’sh e a l t h( Q 5 ) .
The questionnaires Q2 and Q3 included questions on
different allergic diseases in parents/siblings (including
family eczema-history) as well as on indoor climate,
infections, medication, vaccines, day-care, exposure to
nicotine, pets, breastfeeding and diet. Q5 included ques-
tions on different health issues in index child with
emphasize on allergy related disorders. The latter ques-
tions were adopted from the International Study of
Asthma and Allergies in Childhood (ISAAC) protocol
and modified to fit the actual age group [20].
By March 2009 some 2657 parents (54.6%) had com-
pleted Q2 as well as the child’s health-questionnaire at
the age of 2 years (Q5), and these are included in the
6 weeks cohort. The 1 year cohort comprises 3087
parents (60%) who had completed Q3 together with
Q5 (table 1).
T h e s et w oc o h o r t s( 6w e e k s ,N=2 6 5 7a n d1y e a r ,N
= 3087) were used to prospectively study reported
family eczema-history and association to eczema in
index child reported at 2 year.
-Study variables
-The outcome variable studied was ever eczema reported
at the age of 2 years (Q5). The index child was defined
as having eczema if both questions “Has your child ever
had eczema?” and “Has your child ever had an itchy
rash which was coming and going for at least 6
months?” were answered positively [21].
Family eczema-history and exposure variables were
assessed in Q2 and Q3.
-Family eczema- history
Eczema in mother, father or sibling was defined as “yes”
i fa n yo n eo ft h eq u e s t i o n s“have you, the child’sf a t h e r
or any of your joint children ever had eczema” or “have
you, the child’s father or any of your joint children had
eczema or used medication against eczema during the
last 12 months” were ticked “yes” for mother, father or
sibling.
The reporting of family eczema history was then cate-
gorized into the seven different family eczema groups
possible; “mother only”, “father only”, “sibling only”,
“mother and father”, “mother and sibling”, “father and
sibling”, “mother, father and sibling”.
-Exposure variables
The term “breastfeeding now” was used regardless of
whether or not solid food or formulas was given to the
child in addition to breast milk.
“Current smoking mother” was regarded as “yes” when
the question “do you smoke now?” was answered
positively.
Maternal and paternal level of education was not
accounted for in the original questionnaire. Thus, home-
owner status from the questionnaire was used as a
proxy for socioeconomic status.
“Dampness” was defined “yes” when the sum of 8 dif-
ferent questions concerning damp/mould at home was 3
or more.
-Ethics
All parents signed a written consent form to participate
in the PACT study. The study was approved by the
Regional Committee for Medical Research Ethics and
the Norwegian data Inspectorate Board (Ref 120-2000)
(Ref 2003/953-3 KBE/-).
-Statistics
Univariate associations between eczema in index child
and different family eczema-groups as well as the
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logistic regression.
Associations adjusted for potential confounders were
obtained by logistic regression models. Maternal age
was used as a linear variable in the regression analysis.
All other explanatory variables were either dichotomized
or categorized. Dummy variables were made when the
independent variables contained more than two cate-
gories. Family eczema-groups were also categorized, and
those with no family history of eczema (mother, father
or sibling) were set as reference group.
The logistic regression models were adjusted for con-
founding factors identified by ap r i o r iknowledge to the
problem being studied. In the final multivariable regres-
sion analysis, adjustments were made for gender, home-
owner, current smoking mother, breastfeeding, keeping
a dog and age of mother at the time of birth.
A separate model was made for older siblings with
and without eczema. In addition to adjustment for the a
priori defined confounding factors, adjustment was
made for eczema mother and eczema father. Interaction
between eczema mother and eczema father was tested.
In the multivariable analysis the number of missing var-
ied for each variable under study, but never exceeded 9%.
Unadjusted and adjusted associations are presented as
odds ratios (OR, aOR). 95% confidence intervals (CI)
were estimated for binominal distributed data.
Statistical Package for Social Science version 15.0
(SPSS inc., Chicago; IL, USA.) and STATA version 11.2
for Windows (STATA Corporation, College Station, TX,
USA) were used for the analyses.
Results
Some 13.7% and 14.2% of the girls, and 15.9% and 16.1%
of the boys reported eczema at 2 years of age in the 6-
week cohort (N = 2657) and in the 1-year cohort (N =
3087), respectively.
When exposure was reported at 6 weeks, only some
6% of the index children with eczema had had their first
symptoms of eczema, whereas the corresponding num-
ber was about 80% among those who reported exposure
at 1 year.
Some 77% of children in the 6-week cohort also
attended the 1-year cohort. Between 6 weeks and 1 year,
some 9.6% of these parents changed their answer from
“no” to “yes” regarding whether or not the index child
had a sibling with eczema or not. Among those with
eczema in index child reported at 2 years, some 28.5%
changed their answer from “no” to “yes” from 6 weeks
to 1 year, as opposed to some 6.4% among those with-
out eczema in index child 2 years (data not shown).
In univariate analyses, keeping a dog was the only sta-
tistically significant environmental factor associated with
reported eczema at 2 years of age in both cohorts.
Table 1 Characteristics of the two study populations with exposure reported at 6 weeks and 1 year
Exposure reported at 6 weeks, N = 2657 Exposure reported at 1 year, N = 3087
Reported exposure
a n % (95% CI) n % 95% CI
Gender Male 1333 50.2 (48.3-52.1) 1529 49.5 (47.8-51.3)
Homeowner Yes 2242 84.4 (82.9-85.7) 2680 86.8 (85.6-88.0)
Cat Yes 239 9.0 (7.9-10.1) 266 8.6 (7.7-9.7)
Dog Yes 247 9.3 (8.2-10.5) 249 8.1 (7.1-9.1)
Bird Yes 63 2.4 (1.8-3.0) 70 2.3 (1.8-2.9)
Dampness Yes 105 4.0 (3.2-4.8) 117 3.8 (3.1-4.5)
Maternal current smoking Yes 189 7.1 (6.2-8.2) 453 14.7 (13.4-16.0)
Paternal current smoking Yes 399 15.0 (13.7-16.4) 499 16.2 (14.9-17.5)
Premature birth, < 37 weeks Yes 75 2.8 (2.2-3.5) 75 2.4 (1.9-3.0)
Birth-weight <2500gr 74 2.8 (2.2-3.5) 105 3.4 (2.8-4.1)
2500-3999gr 1937 72.9 (71.2-74.6) 2196 71.1 (69.5-72.7)
≥4000gr 623 23.4 (21.8-25.1) 691 22.4 (20.9-23.9)
Breastfeeding now Yes 2481 93.4 (92.4-94.3) 1114 36.1 (34.4-37.8)
Number of siblings 0 1172 44.1 (42.2-46.0) 1343 43.5 (41.7-45.3)
1 920 34.6 (32.8-36.5) 1033 33.5 (31.8-35.2)
2 or more 533 20.1 (18.6-21.6) 711 23.0 (21.6-24.6)
Any kind of infection, child Yes 903 34.0 (32.2-35.8) 2983 96.6 (95.9-97.2)
Antibiotics ever, child Yes 58 2.2 (1.7-2.8) 706 22.9 (21.4-24.4)
mean range SD mean range SD
Maternal age 30.1 17-48 4.49 29.98 17-48 4.46
a Number of missing varies
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tion between eczema in index child at 2 years and dif-
ferent eczema- groups containing only one or both of
the parents, both “eczema mother only” and eczema
father only” were statistically significant in the univariate
analyses [(OR, 1.61; 95% CI 1.18-2.21), (OR, 1.69; 95%
CI 1.16-2.46)] (table 2). When adding reporting of
eczema in a sibling to eczema in one or both of the par-
ents, we found “eczema mother and sibling, not father”
and “eczema mother, father and sibling” to be signifi-
cantly associated with eczema in the index child at 2
years [(OR, 3.41; 95% CI 1.91-6.10) and (OR, 3.15; 95%
CI 1.42-7.02)].
Corresponding univariate analyses of different family
history eczema-groups reported at 1-year showed no dif-
ferences in associations with eczema in index child at 2
years for any of the groups containing one or both of
the parents without a sibling compared to 6 weeks. For
all groups including eczema in siblings there were a
consistent and highly significantly association with
eczema at 2 year in the index child (table 2).
In the adjusted model, we found a significant associa-
tion between “eczema mother only” and “eczema father
only” reported at 6 weeks and eczema in the index child
at 2 years [(aOR, 1.57; 95% CI 1.13-2.18), (aOR, 1.73; 95%
CI 1.18-2.55)] (table 3). No association was found with
“eczema sibling only” (aOR, 1.31; 95% CI 0.77-2.23).
When adapting the same model on reported eczema
in mother, father and sibling at 1 year, we found a sig-
nificant association with eczema at 2 years in all groups
but “eczema mother and father” (Table 3). As opposed
to the family eczema-history reported at 6 weeks, a sig-
nificant association was observed for “eczema sibling
only” (aOR, 3.13; 95% CI 2.27-4.33). Adding eczema in
sibling to either of the eczema parent groups signifi-
cantly strengthened the associations in the 1 year
cohort; “eczema mother and sibling, not father” (aOR,
4.48; 95% CI 2.96-6.78), “eczema father and sibling, not
mother” (aOR, 5.43; 95% CI 3.27-9.02).
In the model testing association between siblings with
and without eczema and association to eczema in index
child 2 years, we found a significant association for sib-
lings with eczema in the 1 year cohort only (aOR, 2.18;
95% CI 1.63-2.92). No interaction between eczema
mother and father was found in either of the cohorts (p
for interaction = 0.48 at 6 weeks, p for interaction =
0.10 at 1 year) (data not shown).
Table 2 Univariate association between different family eczema-groups and eczema 2 years








Reported 6 weeks Reported at 1 year
No family eczema
a 12.5% (217/1738) 1.0 No family eczema
a 10.7% (201/1885) 1.0
Eczema mother only 18.7% (61/326) 1.61
(1.18-2.21)
Eczema mother only 16.7% (59/354) 1.68 (1.22-
2.30)
Eczema father only 19.4% (39/201) 1.69
(1.16-2.46)
Eczema father only 18.1% (39/215) 1.86 (1.27-
2.71)




Eczema mother and father,
not sibling(s)
16.0% (12/75) 1.60 (0.85-
3.01)
Eczema sibling(s) only 16.9% (22/130) 1.43
(0.88-2.31)
Eczema sibling(s) only 25.5% (67/263) 2.86 (2.09-
3.92)




Eczema mother and sibling
(s), not father
33.9% (42/124) 4.29 (2.88-
6.40)




Eczema father and sibling
(s), not mother
37.5% (27/72) 5.03 (3.05-
8.28)




Eczema mother, father and
sibling(s)
40.0% (14/35) 5.59 (2.80-
11.16)
a No family eczema is the reference point for all other family eczema-groups
Table 3 Adjusted association between different family






aOR (95% CI) aOR (95% CI)
Eczema mother only 1.57 (1.14-
2.18)
1.62 (1.17-2.24)
Eczema father only 1.73 (1.18-
2.55)
1.98 (1.35-2.90)





Eczema sibling only 1.31 (0.77-
2.23)
3.13 (2.27-4.33)














a ) No family eczema is the reference point for all other family eczema-groups
b ) Model adjusted for gender, homeowner, current smoking mother,
breastfeeding, keeping a dog and age of mother at time of birth.
Saunes et al. BMC Dermatology 2011, 11:11
http://www.biomedcentral.com/1471-5945/11/11
Page 4 of 7Discussion
In this large population based study with reports of
family eczema-history at two different points of time, we
found that having either parent with eczema was signifi-
cantly associated with reported eczema at the age of 2
years. The associations were consistent when reported
at 6-weeks as well as 1 year. Having one or several sib-
lings with eczema, with or without either of the parents
with eczema reported at 1 year, was also strongly asso-
ciated with reported eczema at 2 years and significantly
stronger for siblings only.
We have data on exposure reported at 6 weeks and 1
year. Although the reporting of exposure was at two dif-
ferent points of time, the two cohorts are comparable.
Some 77% of those who answered Q2 (6 weeks) also
answered Q3 (1 year) as well as Q5 (2 years). The two
cohorts are generated from the same geographic area
(the city of Trondheim), during the same time-period,
and by the same midwifes and GPs.
Although eczema is a relatively prevalent disease
among children in the western world, most children have
mild degree of disease, making the diagnosis and differ-
entiating between different phenotypes of the disease as
well as mild cases challenging [21-23]. We found the pre-
valence of reported eczema 2 years to about 15% both
among those who reported the family eczema history at
6-week and those who reported at 1 year, indicating a
high reliability of the questions. Any misclassification of
eczema cases might therefore be non-differential, and if
so may have diluted the associations.
Several studies describe a maternal line of inheritance
concerning eczema [5,6,22]. This maternal line of inheri-
tance has led investigators to hypothesize that environ-
mental influences operating in utero or in early infancy
may be essential in determining disease expression [24].
In this study eczema in the index child was significantly
associated with eczema in mothers as well as fathers.
This finding is in accordance with several others [8,9,25]
and not supportive to the hypothesis of paternal geno-
mic imprinting. However, parental recall bias should be
taken into consideration also here. Any one parent who
followed the child was asked to participate in the
PACT-study. One limitation in this study is the fact that
we don’t know which parent filled in the questionnaire.
Since many of the women were included during preg-
nancy and during their child’s first year of living, we
assume that mothers most likely have accepted to parti-
cipate in the study when visiting her GP or midwife. It
is therefore most likely that mothers have filled in the
questionnaires. In both cohorts more boys than girls
reported eczema at age 2 years. Despite this, more
mothers than fathers reported to have ever eczema.
When studying recall bias in parental questioning, a
German group found that mothers tended to report
more atopic diseases in a second questionnaire than in
the first, whilst fathers were influenced by their child’s
development of atopic disease [16]. In families without
childhood eczema the sensitivity for mothers reporting
paternal eczema was lower than in families with at least
one child with eczema. The specificity was about the
same [26]. Although effect size is small in a population
setting, filaggrin haploinsufficiency is a highly penetrant
trait, and associated with increased eczema severity [27].
I ti st h e r e f o r el i k e l yt h a ts e v e r ee c z e m ai na n yo n eo f
the parents represent a greater risk of eczema in the off-
spring. It seems also likely, that mothers more often
would report a positive paternal history of eczema if the
disease was severe or persisted into adulthood. The lat-
ter is supported by a Swedish study, who found that
recall of childhood eczema history among adults was
influenced by several factors such as high prevalence of
eczema after the age of 15, more visits to the physician
after the age of 15, more hand eczema and more sick-
leave due to eczema [17]. Since mothers most likely
have filled in our questionnaires, an overestimation of
the association between paternal eczema and eczema in
index child is possible. This might be due either to
more severe eczema in fathers or increased awareness
due to development of eczema in one of the children.
Both could explain the lack of a maternal line of inheri-
tance in this study.
When family history of eczema is studied, allergy
related disorders in siblings are seldom accounted for in
the risk analysis. We found that, although having any
one parent with eczema was associated with eczema in
index child at 2 years, having one or several siblings
with eczema together with mother and/or father with
eczema was strongly associated with eczema in index
child 2 years when reports were collected at 1 year. This
association was also seen when eczema was reported
only in sibling(s). There are different interpretations of
t h e s ef i n d i n g s .O n ep o s s i b l ee x p l a n a t i o nc o u l db et h a t
this is a reflection of a parental genetic disposition with
incomplete penetrance [4]. Mutations in the gene
encoding filaggrin (FLG) have been identified as a strong
predisposing factors for eczema [28] and especially
severe phenotypes of the disease [29], but other candi-
date genes are also under investigation [11]. Different
environmental factors can alter the expression of differ-
ent genes, as have been showed with the exposure to cat
within the first year of life in those who carry mutations
of FLG [30]. Other environmental factors such as early
colonisation from maternal microbial flora as well as
shared environment among siblings with the same
genetic predisposition may act in a similar way and
explain the “eczema-sibling-effect” in this study.
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reported at 6 weeks. Awareness of disease in first child
with mild disease might be absent until same kinds of
symptoms as e.g. dry skin is observed in second child.
Also, in mild cases of eczema a significant proportion of
t h ec h i l d r e na r ed i s e a s ef r e eb yt h ea g eo f3y e a r s[ 3 1 ] .
In this study, some 28.5% of parents with eczema in
index child at 2 years changed their answer from “no”
when reported at 6 weeks to “yes” when reported at 1
year regarding the question on whether or not siblings
had eczema, as opposed to 6.4% among those without
eczema in index child. These findings could be inter-
preted as an increase in awareness since some 80% of
index children had developed symptoms on eczema at
age 1 year. Another interpretation is that some of the
older siblings have not yet been diagnosed with eczema.
This is however less likely, since a majority of children
with eczema starts with their disease during their first
year of life [31].
In a German study of children 9-11 years old having
two first degree relatives with the same atopic disease
was highly associated with eczema [4]. Diepgen & Blett-
ner found a stronger correlation between siblings than
between siblings and parents for all atopic diseases, also
atopic dermatitis [5]. Eczema in an older sibling was
also found to be an independent risk factor for eczema
among 4-years old in Sweden [9].
When only some 60% of those finishing the question-
naires on exposure were answering the questionnaires
on health, one could argue that the data are prone to
self-selection. In both cohorts the lost-to-follow-up
group contained more current smoking mothers and
fewer homeowners, indicating a lower socio-economic
status (data not shown). However, other exposure data,
including reported family eczema-history did not differ
among those who followed up and those who did not.
Another limitation of the s t u d yw a st h er e p o r t i n g
eczema in parents and siblings without a clinical verifi-
cation. The question “have you, the child’s father or any
of your joint children ever had eczema” is a core ISAAC
questions, but is most often used in combination with a
question on rash located in typical places or diagnosis
verified by a doctor. To the best of our knowledge, the
question has not been validated in an adult population.
However, the almost similar phrasing “have you ever
had childhood eczema” was validated among adults in a
Swedish population. The sensitivity and specificity of
this question was 89.9% and 70.7%, respectively [32],
and an overestimation of the reported prevalence of
childhood eczema among adults is therefore likely.
Regarding the use of this question among children (sib-
lings), we have validated this in a former publication
[21]. This question alone, without a question identifying
rash on typical location, gave a sensitivity of 96.8% and
a specificity of 68.0% when validated against the UK
Working Party Criteria. Adding a question of rash on
typical locations decreased the sensitivity whereas the
specificity increased. This gives reason to believe, that
there might be an overestimation of reported eczema
among the siblings, since other forms of dermatitis in
young children, such as seborrhoeic dermatitis as well
as nappy dermatitis might have been included. However,
in case of such a misclassification, there is no reason to
believe that this has changed from 6 weeks to 1 year,
and could therefore not explain the differences in
reporting of eczema in siblings in the two cohorts.
T h es t r e n g t h so ft h i ss t u d ya r et h el a r g en u m b e ro f
unselected participants as well as the prospective design.
The consistency of reported eczema indicates a high
reliability of the questions and the prevalence of
reported eczema is well in line with the prevalence
found in the PACT endpoint-study [21]. In addition, the
focus is on eczema-groups only, since other studies have
showed that parental eczema may be a better marker
for eczema in the offspring than other parental atopic
diseases [8,33].
Conclusions
We found that reporting having a sibling with eczema at
1 year was significantly associated with reported eczema
at 2 years. Eczema in mother as well as eczema in father
was both associated with eczema 2 years. When family
eczema-history was reported when index child was 1
years of age, the associations with eczema 2 years were
significantly stronger for both parents if sibling(s) of the
index child had eczema, and association was signifi-
cantly stronger for sibling(s) reported at 1 year com-
pared to 6 weeks. However, although siblings had
eczema, the shared environment by mother and child
did not result in any difference between maternal and
paternal associations to eczema 2 years in index child.
The finding of different associations when family-
eczema history was reported at 6 weeks compared to
when family eczema-history was reported at 1 year indi-
cate bias in information gathering and has important
implications on comparability of studies measuring the
effect of older sibling disease on index child`s risk of
eczema.
Acknowledgements
The authors would like to thank all parents, children, general practitioners
and midwifes for participating in the study. A special thank to bioengineer
Guri Helmersen and nurse Else Bartnes for their invaluable contribution in
the PACT-study.
Funding for the PACT study was obtained from the Norwegian Department
of Health and Social affairs 1997-2003, and the control cohort was funded
by AstraZeneca Norway AS 2000-2001. A university scholarship from the
Norwegian University of Science and Technology (NTNU) is funding MS from
2008-2012. A university scholarship from NTNU and a scholarship from
Norwegian Research Council 1999-2003 funded TØ and OS. Grants were
Saunes et al. BMC Dermatology 2011, 11:11
http://www.biomedcentral.com/1471-5945/11/11
Page 6 of 7obtained from the Norwegian Medical Association and SINTEF Unimed 1999.
A scholarship from Nidarosfondet funded TØ in 2007.
Author details
1Department of Public Health and General Practice, Norwegian University of
Science and Technology, Trondheim, Norway.
2Department of Dermatology,
St. Olavs Hospital, Trondheim University Hospital, Norway.
Authors’ contributions
MS participated in the design of the study, performed statistical analysis and
drafted the manuscript. TØ, OS and RJ conceived the study, participated in
its design and co-ordination and helped draft the manuscript.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 17 December 2010 Accepted: 20 May 2011
Published: 20 May 2011
References
1. Bieber T: Atopic dermatitis. N Engl J Med 2008, 358(14):1483-1494.
2. Schultz Larsen FV, Holm NV: Atopic dermatitis in a population based twin
series. Concordance rates and heritability estimation. Acta Derm Venereol
Suppl (Stockh) 1985, 114:159.
3. Ruiz RG, Kemeny DM, Price JF: Higher risk of infantile atopic dermatitis
from maternal atopy than from paternal atopy. Clin Exp Allergy 1992,
22(8):762-766.
4. Dold S, Wjst M, von Mutius E, Reitmeir P, Stiepel E: Genetic risk for asthma,
allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992,
67(8):1018-1022.
5. Diepgen TL, Blettner M: Analysis of familial aggregation of atopic eczema
and other atopic diseases by ODDS RATIO regression models. J Invest
Dermatol 1996, 106(5):977-981.
6. Wang IJ, Guo YL, Hwang KC, Hsieh WS, Chuang YL, Lin SJ, Chen PC:
Genetic and environmental predictors for pediatric atopic dermatitis.
Acta Paediatr Taiwan 2006, 47(5):238-242.
7. Bisgaard H, Halkjaer LB, Hinge R, Giwercman C, Palmer C, Silveira L,
Strand M: Risk analysis of early childhood eczema. J Allergy Clin Immunol
2009, 123(6):1355-1360, e1355.
8. Wadonda-Kabondo N, Sterne JA, Golding J, Kennedy CT, Archer CB,
Dunnill MG: Association of parental eczema, hayfever, and asthma with
atopic dermatitis in infancy: birth cohort study. Arch Dis Child 2004,
89(10):917-921.
9. Bohme M, Wickman M, Lennart Nordvall S, Svartengren M, Wahlgren CF:
Family history and risk of atopic dermatitis in children up to 4 years. Clin
Exp Allergy 2003, 33(9):1226-1231.
10. Zutavern A, Hirsch T, Leupold W, Weiland S, Keil U, von Mutius E: Atopic
dermatitis, extrinsic atopic dermatitis and the hygiene hypothesis:
results from a cross-sectional study. Clin Exp Allergy 2005,
35(10):1301-1308.
11. Morar N, Willis-Owen SA, Moffatt MF, Cookson WO: The genetics of atopic
dermatitis. J Allergy Clin Immunol 2006, 118(1):24-34, quiz 35-26.
12. O’Regan GM, Sandilands A, McLean WH, Irvine AD: Filaggrin in atopic
dermatitis. J Allergy Clin Immunol 2009, 124(3 Suppl 2):R2-6.
13. Strachan DP: Hay fever, hygiene, and household size. BMJ 1989,
299(6710):1259-1260.
14. Karmaus W, Botezan C: Does a higher number of siblings protect against
the development of allergy and asthma? A review. J Epidemiol
Community Health 2002, 56(3):209-217.
15. Kjellman NI: Atopic disease in seven-year-old children. Incidence in
relation to family history. Acta Paediatr Scand 1977, 66(4):465-471.
16. Kulig M, Bergmann R, Edenharter G, Wahn U: Does allergy in parents
depend on allergy in their children? Recall bias in parental questioning
of atopic diseases. Multicenter Allergy Study Group. J Allergy Clin
Immunol 2000, 105(2 Pt 1):274-278.
17. Moberg C, Meding B, Stenberg B, Svensson A, Lindberg M: Remembering
childhood atopic dermatitis as an adult: factors that influence
recollection. Br J Dermatol 2006, 155(3):557-560.
18. Naleway AL, Belongia EA, Greenlee RT, Kieke BA Jr, Chen RT, Shay DK:
Eczematous skin disease and recall of past diagnoses: implications for
smallpox vaccination. Ann Intern Med 2003, 139(1):1-7.
19. Storro O, Oien T, Dotterud CK, Jenssen JA, Johnsen R: A primary health-
care intervention on pre- and postnatal risk factor behavior to prevent
childhood allergy. The Prevention of Allergy among Children in
Trondheim (PACT) study. BMC Public Health 2010, 10(443).
20. Oien T, Storro O, Johnsen R: Assessing atopic disease in children two to
six years old: reliability of a revised questionnaire. Prim Care Respir J 2008,
17(3):164-168.
21. Smidesang I, Saunes M, Storro O, Oien T, Holmen TL, Johnsen R,
Henriksen AH: Atopic dermatitis among 2-year olds; high prevalence, but
predominantly mild disease–the PACT study, Norway. Pediatr Dermatol
2008, 25(1):13-18.
22. Johnke H, Vach W, Norberg LA, Bindslev-Jensen C, Host A, Andersen KE: A
comparison between criteria for diagnosing atopic eczema in infants. Br
J Dermatol 2005, 153(2):352-358.
23. Williams HC: Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000,
25(7):522-529.
24. Godfrey K: Fetal and perinatal origins of atopic dermatitis. In Atopic
dermatitis. Edited by: Williams HC. Cambridge: Cambridge University Press;
2000:125-138.
25. Wen HJ, Chen PC, Chiang TL, Lin SJ, Chuang YL, Guo YL: Predicting risk for
early infantile atopic dermatitis by hereditary and environmental factors.
Br J Dermatol 2009, 161(5):1166-1172.
26. Litonjua AA, Carey VJ, Burge HA, Weiss ST, Gold DR: Parental history and
the risk for childhood asthma. Does mother confer more risk than
father? Am J Respir Crit Care Med 1998, 158(1):176-181.
27. Brown SJ, Relton CL, Liao H, Zhao Y, Sandilands A, McLean WH, Cordell HJ,
Reynolds NJ: Filaggrin haploinsufficiency is highly penetrant and is
associated with increased severity of eczema: further delineation of the
skin phenotype in a prospective epidemiological study of 792 school
children. Br J Dermatol 2009, 161(4):884-889.
28. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP,
Goudie DR, Sandilands A, Campbell LE, Smith FJ, O’Regan GM, Watson RM,
Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S,
Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K,
Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common loss-of-
function variants of the epidermal barrier protein filaggrin are a major
predisposing factor for atopic dermatitis. Nat Genet 2006, 38(4):441-446.
29. Ekelund E, Lieden A, Link J, Lee SP, D’Amato M, Palmer CN, Kockum I,
Bradley M: Loss-of-function variants of the filaggrin gene are associated
with atopic eczema and associated phenotypes in Swedish families. Acta
Derm Venereol 2008, 88(1):15-19.
30. Bisgaard H, Simpson A, Palmer CN, Bonnelykke K, McLean I,
Mukhopadhyay S, Pipper CB, Halkjaer LB, Lipworth B, Hankinson J,
Woodcock A, Custovic A: Gene-environment interaction in the onset of
eczema in infancy: filaggrin loss-of-function mutations enhanced by
neonatal cat exposure. PLoS Med 2008, 5(6):e131.
31. Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, Wahn U: The
natural course of atopic dermatitis from birth to age 7 years and the
association with asthma. J Allergy Clin Immunol 2004, 113(5):925-931.
32. Stenberg B, Lindberg M, Meding B, Svensson A: Is the question ‘Have you
had childhood eczema?’ useful for assessing childhood atopic eczema in
adult population surveys? Contact Dermatitis 2006, 54(6):334-337.
33. Alm B, Aberg N, Erdes L, Mollborg P, Pettersson R, Norvenius SG, Goksor E,
Wennergren G: Early introduction of fish decreases the risk of eczema in
infants. Arch Dis Child 2009, 94(1):11-15.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-5945/11/11/prepub
doi:10.1186/1471-5945-11-11
Cite this article as: Saunes et al.: Family eczema-history in 2-year olds
with eczema; a prospective, population-based study. The PACT-study,
Norway. BMC Dermatology 2011 11:11.
Saunes et al. BMC Dermatology 2011, 11:11
http://www.biomedcentral.com/1471-5945/11/11
Page 7 of 7